Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...

Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indications ...

VANCOUVER, BC / ACCESS Newswire / January 6, 2026 / George Sanders, President of Goldcliff Resource Corporation ("Goldcliff" or the "Company") , reports that results from the Company's 2025 ...

These achievements, like many of the UB’s research endeavors, are poised to have a wide-ranging and long-lasting positive ...